Michelle He is the Associate at AIF, where she executes due diligence on potential opportunities and supports AIF’s existing portfolio. Leveraging her statistics/neuroscience background and a solid financial foundation developed at Morgan Stanley, she builds valuation models across sectors, including data-enabled services, SaaS, and biotechnology. Her valuation work is integral to AIF’s deal prioritization and decision-making process. For existing portfolio companies, she monitors financial and operational conditions, industry dynamics and works at a strategic capacity with select companies to ensure meaningful business development and growth.

Before joining AIF, Michelle was an Investment Banking Analyst at Morgan Stanley in the Financial Sponsors Group. She advised private equity firms on capital issuances and transactions involving their portfolio companies, arranging over $900 million in financing packages on the backs of LBOs, mergers, IPOs, and recapitalizations.

Michelle holds a B.S. double major in Business Administration and Statistics/Analytics, with a minor in Neuroscience, from the University of North Carolina at Chapel Hill. She graduated with highest honors and distinction and is a member of Phi Beta Kappa. Her pro-bono work with a startup focused on ASD diagnosis attests to her early interest in autism and mental health.